Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study.

Ayush Mohan,Snigdha Komakula, Suhas Murali,Pooja Anand,Dyuti Shah,V Y Vishnu,Awadh Kishor Pandit,Ayush Agarwal,Deepti Vibha,Mamta Bhushan Singh,M V Padma Srivastava,Rohit Bhatia

Annals of Indian Academy of Neurology（2023）

引用 2|浏览11

暂无评分

摘要

This present study observed no difference in the efficacy and safety between biosimilar TNK and rTPA. Our findings are in concordance with published trials showing equivalence between the two molecules.

查看译文

关键词

Biosimilar pharmaceuticals,fibrinolytic agents,ischemic stroke,tenecteplase,tissue plasminogen activator

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要